Accession Number: | 0001179110-22-000119 |
Date: | 2021-12-31 |
Issuer: | ABBVIE INC. (ABBV) |
Original Submission Date: |
RAPP EDWARD J
1 N. WAUKEGAN ROAD
NORTH CHICAGO, IL 60064
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK EQUIVALENT UNITS | 135.4 | 2021-12-31 | deemed execution date | A | 260 (a) | common stock 260 | $135.40 | 21,434 | direct |
ID | footnote |
---|---|
f1 | director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. the stock equivalent units earn the same return as if the fees were invested in abbvie stock. |
f2 | balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. |